Annual CFO
-$39.33 M
-$20.86 M-112.91%
December 31, 2023
Summary
- As of February 8, 2025, ITRM annual cash flow from operations is -$39.33 million, with the most recent change of -$20.86 million (-112.91%) on December 31, 2023.
- During the last 3 years, ITRM annual CFO has risen by +$15.20 million (+27.87%).
- ITRM annual CFO is now -248.11% below its all-time high of -$11.30 million, reached on December 31, 2016.
Performance
ITRM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.67 M
+$4.09 M+60.47%
September 30, 2024
Summary
- As of February 8, 2025, ITRM quarterly cash flow from operations is -$2.67 million, with the most recent change of +$4.09 million (+60.47%) on September 30, 2024.
- Over the past year, ITRM quarterly CFO has stayed the same.
- ITRM quarterly CFO is now -136.04% below its all-time high of -$1.13 million, reached on March 31, 2021.
Performance
ITRM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$35.36 M
+$6.59 M+15.72%
September 30, 2024
Summary
- As of February 8, 2025, ITRM TTM cash flow from operations is -$35.36 million, with the most recent change of +$6.59 million (+15.72%) on September 30, 2024.
- Over the past year, ITRM TTM CFO has stayed the same.
- ITRM TTM CFO is now -550.54% below its all-time high of -$5.43 million, reached on March 31, 2017.
Performance
ITRM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ITRM Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -112.9% | 0.0% | 0.0% |
| 3 y3 years | +27.9% | 0.0% | 0.0% |
| 5 y5 years | +49.1% | 0.0% | 0.0% |
ITRM Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -148.3% | at low | -8.7% | +79.6% | -123.2% | +17.4% |
| 5 y | 5-year | -148.3% | +52.0% | -136.0% | +90.2% | -123.2% | +62.5% |
| alltime | all time | -248.1% | +52.0% | -136.0% | +90.3% | -550.5% | +62.5% |
Iterum Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.67 M(-60.5%) | -$35.36 M(-15.7%) |
| Jun 2024 | - | -$6.76 M(-48.3%) | -$41.95 M(-2.0%) |
| Mar 2024 | - | -$13.08 M(+1.9%) | -$42.82 M(+8.9%) |
| Dec 2023 | -$39.33 M(+112.9%) | -$12.84 M(+38.6%) | -$39.33 M(+27.9%) |
| Sep 2023 | - | -$9.27 M(+21.4%) | -$30.75 M(+18.2%) |
| Jun 2023 | - | -$7.63 M(-20.4%) | -$26.03 M(+5.5%) |
| Mar 2023 | - | -$9.59 M(+124.9%) | -$24.66 M(+33.5%) |
| Dec 2022 | -$18.47 M(+16.6%) | -$4.26 M(-6.0%) | -$18.47 M(+10.8%) |
| Sep 2022 | - | -$4.54 M(-27.5%) | -$16.67 M(+3.9%) |
| Jun 2022 | - | -$6.26 M(+84.0%) | -$16.04 M(-11.5%) |
| Mar 2022 | - | -$3.40 M(+38.5%) | -$18.11 M(+14.3%) |
| Dec 2021 | -$15.84 M(-70.9%) | -$2.46 M(-37.1%) | -$15.84 M(-29.3%) |
| Sep 2021 | - | -$3.91 M(-53.1%) | -$22.41 M(-2.2%) |
| Jun 2021 | - | -$8.34 M(+636.8%) | -$22.92 M(-18.9%) |
| Mar 2021 | - | -$1.13 M(-87.5%) | -$28.27 M(-48.2%) |
| Dec 2020 | -$54.53 M | -$9.03 M(+104.5%) | -$54.53 M(-20.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$4.42 M(-67.7%) | -$68.55 M(-23.4%) |
| Jun 2020 | - | -$13.69 M(-50.0%) | -$89.54 M(-5.0%) |
| Mar 2020 | - | -$27.39 M(+18.8%) | -$94.26 M(+15.1%) |
| Dec 2019 | -$81.92 M(+6.0%) | -$23.05 M(-9.3%) | -$81.92 M(-2.5%) |
| Sep 2019 | - | -$25.41 M(+38.1%) | -$84.06 M(-2.4%) |
| Jun 2019 | - | -$18.41 M(+22.3%) | -$86.14 M(+6.8%) |
| Mar 2019 | - | -$15.05 M(-40.2%) | -$80.67 M(+4.4%) |
| Dec 2018 | -$77.25 M(+152.4%) | -$25.19 M(-8.4%) | -$77.25 M(+24.2%) |
| Sep 2018 | - | -$27.50 M(+112.6%) | -$62.19 M(+55.0%) |
| Jun 2018 | - | -$12.93 M(+11.1%) | -$40.13 M(+9.0%) |
| Mar 2018 | - | -$11.64 M(+15.0%) | -$36.81 M(+20.3%) |
| Dec 2017 | -$30.60 M(+170.9%) | -$10.12 M(+86.2%) | -$30.60 M(+49.4%) |
| Sep 2017 | - | -$5.44 M(-43.4%) | -$20.48 M(+36.1%) |
| Jun 2017 | - | -$9.61 M(+76.8%) | -$15.04 M(+176.8%) |
| Mar 2017 | - | -$5.43 M | -$5.43 M |
| Dec 2016 | -$11.30 M | - | - |
FAQ
- What is Iterum Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Iterum Therapeutics?
- What is Iterum Therapeutics annual CFO year-on-year change?
- What is Iterum Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Iterum Therapeutics?
- What is Iterum Therapeutics quarterly CFO year-on-year change?
- What is Iterum Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Iterum Therapeutics?
- What is Iterum Therapeutics TTM CFO year-on-year change?
What is Iterum Therapeutics annual cash flow from operations?
The current annual CFO of ITRM is -$39.33 M
What is the all time high annual CFO for Iterum Therapeutics?
Iterum Therapeutics all-time high annual cash flow from operations is -$11.30 M
What is Iterum Therapeutics annual CFO year-on-year change?
Over the past year, ITRM annual cash flow from operations has changed by -$20.86 M (-112.91%)
What is Iterum Therapeutics quarterly cash flow from operations?
The current quarterly CFO of ITRM is -$2.67 M
What is the all time high quarterly CFO for Iterum Therapeutics?
Iterum Therapeutics all-time high quarterly cash flow from operations is -$1.13 M
What is Iterum Therapeutics quarterly CFO year-on-year change?
Over the past year, ITRM quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Iterum Therapeutics TTM cash flow from operations?
The current TTM CFO of ITRM is -$35.36 M
What is the all time high TTM CFO for Iterum Therapeutics?
Iterum Therapeutics all-time high TTM cash flow from operations is -$5.43 M
What is Iterum Therapeutics TTM CFO year-on-year change?
Over the past year, ITRM TTM cash flow from operations has changed by $0.00 (0.00%)